<

 
Data updated 2025-04-24 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date18711796.5 (espacenet)  (Federated)  (European Patent Register), 20180308
Patent/reg. no. and dateDK/EP 3592742, 20210519
Publication date20200115
Priority no. and dateUS 201762469073 P, 20170309
EP pub. no. and date EP 3592742 20200115
Effective date
Applicant/ownerTheravance Biopharma R&D IP, LLC, 901 Gateway Boulevard
South San Francisco, CA 94080, US
Applicant ref. no.BT/GP/165057
InventorFATHEREE, Paul R., 921 Minnesota Street
San Francisco, California 94107, US,
BRANDT, Gary E. L., 2160 Buena Vista Avenue
Alameda, California 94501, US,
VAN ORDEN, Lori Jean, 362 Park Street
San Francisco,
California 94110, US,
SMITH, Cameron, 4256 Shelter Creek Lane
San Bruno, California 94066, US,
SULLIVAN, Steven D.E., 1417 17th Avenue
San Francisco, California 94122, US,
KLEINSCHEK, Melanie A., 30 Elizabeth Street
San Francisco, California 94110, US,
CRATER, Glenn D., 7108 Rippling Stone Lane
Raleigh, North Carolina 27612, US
RepresentativeBudde Schou A/S, Dronningens Tværgade 30, 1302 København K
Opponent
IPC ClassA61K 31/397 (2006.01) , A61K 31/437 (2006.01) , A61P 11/00 (2006.01) , C07D 471/04 (2006.01) 
TitleJAK inhibitorer med en 4-leddet heterocyclisk amid
Int. application no.US2018021489
Int. publication no.WO2018165392
Related patent (certificate)
StatusBortfaldet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact